References
- Ruban A, Stoenchev K, Ashrafian H, Teare J. Current treatments for obesity. Clin Med (Lond). 2019 ; 19(3) : 205-12.
- Korean Society for the Study of Obesity. Clinical practice guidelines for obesity. 8th ed. Seoul : Korean Society for the Study of Obesity. 2022 : 14-9, 131-43.
- Nam GE. Current status and epidemiology of adult obesity in Korea. J Korean Med Assoc. 2022 ; 6 5(7) : 394-9.
- Yang YS, Han BD, Han K, Jung JH, Son JW; Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity. Obesity fact sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019. J Obes Metab Syndr. 2022 ; 31(2) : 169-77.
- Park E. The obesity and the metabolic syndrome among Korean adults: based on national representative survey. Korean J Health Promot. 2020 ; 20(4) : 144-50.
- Park JH, Park DJ, Kim H, Park H, Lee B, Nam H, et al. Twelve-year trajectory of disease burden and mortality by obesity level in Korea: analysis of the National Health Insurance Service database. Obes Surg. 2023 ; 33(1) : 105-16.
- Korean Society for the Study of Obesity. 2022 Obesity fact sheet. Seoul : Korean Society for the Study of Obesity. 2022 : 8-13.
- Lee YJ. Assessing quality of life for morbidly obese patient. J Metab Bariatr Surg. 2012 ; 1(2) : 93-7.
- Rhee EJ. Current status of obesity treatment in Korea: based on the 2020 Korean Society for the Study of Obesity guidelines for obesity management. J Korean Med Assoc. 2022 ; 65(7) : 388-92.
- Lee DY, Lee CM. Surgical treatment for obesity. J Korean Med Assoc. 2022 ; 65(7) : 417-22.
- Park H, Huh Y, Kim SH, Yoo MW, Ko CS, Park HS. Longitudinal changes of body weight according to sex.age and metabolic parameters in Korean morbid obese patients after sleeve gastrectomy: 12-month retrospective cohort study. Korean J Fam Pract. 2022 ; 12(3) : 185-92.
- Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020 ; 324(9) : 879-87.
- Kim S, Han K, Kwon O, Lee W, Yoon C, Lee JH. Effect of Korean medicine treatment including Korean medicine counselling on weight loss in patients with morbid obesity: a retrospective chart review. J Korean Med Obes Res. 2021 ; 21(1) : 22-31.
- Han YJ, Cha J. Herbal medicine with diet control and exercise for class III obesity: a case report. J Korean Med Obes Res. 2021 ; 21(2) : 105-11.
- Han HJ, Kim HJ, Park EY, Jang JA, An TH, Seo HS, et al. The effect of oriental obesity therapy on morbid obese patient with type 2 diabetes: two cases report. J Korean Med Obes Res. 2010 ; 10(1) : 57-63.
- Kang EY, Park YB, Kim MY, Park YJ. A study on factors associated with weight loss by 'Gamitaeeumjowee-tang'. J Korean Med Obes Res. 2017 ; 17(2) : 68-76.
- Kim SJ, Seo YH, Lee HS, Chang HK, Cho JH, Kim KW, et al. Research trends of herbal medicines for obesity: mainly since 2015 to 2019. J Korean Med Rehabil. 2020 ; 30(4) : 89-103.
- Yoon NR, Yoo YJ, Kim MJ, Kim SY, Lim YW, Lim HH, et al. Analysis of adverse events in weight loss program in combination with 'Gamitaeeumjowee-tang' and low-calorie diet. J Korean Med Obes Res. 2018 ; 18(1) : 1-9.
- Park MJ, Kim E, Ok JM, Choi KH, Lim YW. Gamitaeeumjowee-tang for weight loss in overweight and obese women with polycystic ovary syndrome: a retrospective chart review. J Korean Med Obes Res. 2022 ; 22(2) : 136-46.
- Lee AR, Lee DY, Kim MJ, Lee HS, Choi KH, Kim SY, et al. Gamitaeeumjowee-tang for weight loss in diabetic patients: a retrospective chart review. J Korean Med. 2021 ; 42(1) : 46-58.
- Kim MJ, Won BY, Kim HJ, Choi KH. Clinical application of Gamitaeeumjowee-tang for overweight or obese hypothyroidism patients: a retrospective chart review. J Korean Med Obes Res. 2023 ; 23(2) : 78-85.
- Lee MK, Cheng BW, Che CT, Hsieh DP. Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation. Toxicol Sci. 2000 ; 56(2) : 424-30.
- Jang IS, Yang CS, Hwang EH. The need for clinical practice guidelines in usage of Mahuang in weight loss. J Korean Med Obes Res. 2007 ; 7(1) : 23-9.
- Jo GW, Ok JM, Kim SY, Lim YW. Review on the efficacy and safety of Mahuang and ephedrine in the treatment of obesity-focused on RCT. J Korean Med. 2017 ; 38(3) : 170-84.
- Park S, Park MJ, Kim E, Lim YW. Review on predictors of weight loss in moderate to severe obesity treatment. J Korean Med Obes Res. 2023 ; 23(2) : 98-111.
- Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015 ; 373(1) : 11-22.
- Wharton S, Haase CL, Kamran E, Liu A, Mancini J, Neish D, et al. Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real-world effectiveness study in Canada. Obes Sci Pract. 2020 ; 6(4) : 439-44.
- Nam SH, Kim SY, Lim YW, Park YB. Review on predictors of weight loss in obesity treatment. J Korean Med Obes Res. 2018 ; 18(2) : 115-27.
- Han JY, Park YJ. Analysis of factors influencing obesity treatment according to initial condition and compliance with medication. J Korean Med Obes Res. 2019 ; 19(1) : 31-41.
- Harsha DW, Bray GA. Weight loss and blood pressure control (Pro). Hypertension. 2008 ; 51(6) : 1420-5.
- Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, et al. Guideline for the diagnosis of drug hypersensitivity reactions. Allergo J Int. 2015 ; 24(3) : 94-105.